Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors
Xiaojia Ren, Diana Boriero, Luksana Chaiswing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 99

Showing 26-50 of 99 citing articles:

Insilico and Invivo protective effect of biochanin-A mitigating doxorubicin- induced cognitive deficits and neuroinflammation: Insights to the role of p-Tau and miR-132
Sarah Hussein, Mai F. Tolba, Haidy E. Michel, et al.
NeuroToxicology (2025)
Closed Access
Chemotherapy-related cognitive impairment and kidney dysfunction
Mariadelina Simeoni, Michele M. Mulholland, Biruh Workeneh, et al.
Nephrology Dialysis Transplantation (2025) Vol. 40, Iss. Supplement_2, pp. ii54-ii63
Open Access
Childhood Neurotoxicity and Brain Resilience to Adverse Events during Adulthood
AnnaLynn M. Williams, Yin Ting Cheung, Geehong Hyun, et al.
Annals of Neurology (2020) Vol. 89, Iss. 3, pp. 534-545
Open Access | Times Cited: 30
Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways
Kate Oppegaard, Carolyn Harris, Joosun Shin, et al.
Cytokine (2021) Vol. 148, pp. 155653-155653
Open Access | Times Cited: 24
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17
Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
Zhimeng Yao, Hongmei Dong, Jianlin Zhu, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 10
Chemotherapy-Mediated Neuronal Aberration
Pradip Kumar Jaiswara, Surendra K. Shukla
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1165-1165
Open Access | Times Cited: 9
Nrf2 Signaling Pathway: a Potential Therapeutic Target in Combating Oxidative Stress and Neurotoxicity in Chemotherapy-Induced Cognitive Impairment
Roshan Lal, Ravinder Naik Dharavath, Kanwaljit Chopra
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 593-608
Closed Access | Times Cited: 9
Chemotherapy-induced cognitive impairment and glia: A new take on chemobrain?
Maria Barbosa-Azevedo, Ana Dias-Carvalho, Félix Carvalho, et al.
Toxicology and Applied Pharmacology (2024) Vol. 492, pp. 117085-117085
Open Access | Times Cited: 3
Ganoderic acid improves 5-fluorouracil-induced cognitive dysfunction in mice
Abudumijiti Abulizi, Jianhua Ran, Yuwei Ye, et al.
Food & Function (2021) Vol. 12, Iss. 24, pp. 12325-12337
Closed Access | Times Cited: 22
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
The protective effect of taurine, piracetam and vinpocetine on etoposideinduced inflammation and brain injury in the serum of female albino rats
Arwa Salam Mohammed, Ansam N Al-Hassani, Rafal Abdulrazaq Al-Rawi, et al.
ecancermedicalscience (2023) Vol. 17
Open Access | Times Cited: 8
Dual-Responsive Dual-Drug-Loaded Bioinspired Polydopamine Nanospheres as an Efficient Therapeutic Nanoplatform against Drug-Resistant Cancer Cells
Yiyan Song, Ping Zhu, Zhihui Xu, et al.
ACS Applied Bio Materials (2020) Vol. 3, Iss. 9, pp. 5730-5740
Closed Access | Times Cited: 21
Cancer treatment induces neuroinflammation and behavioral deficits in mice
Kimberly Demos-Davies, Jessica Lawrence, Allison Rogich, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma
AnnaLynn M. Williams, Wei Liu, Matthew J. Ehrhardt, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1822-1832
Closed Access | Times Cited: 2
Melatonin mitigates cisplatin-induced cognitive impairment in rats and improves hippocampal dendritic spine density
Shahd Qutifan, Tareq Saleh, Nisreen Abu Shahin, et al.
Neuroreport (2024) Vol. 35, Iss. 10, pp. 657-663
Closed Access | Times Cited: 2
Chemotherapy-Related Cognitive Impairment and Changes in Neural Network Dynamics
Sandra Leskinen, Samir Alsalek, Rosivel Galvez, et al.
Neurology (2024) Vol. 104, Iss. 2
Closed Access | Times Cited: 2
Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice
Pi‐Shan Sung, Pei-Wen Chen, Chia‐Jui Yen, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4177-4177
Open Access | Times Cited: 17
Cyclophosphamide and epirubicin induce high apoptosis in microglia cells while epirubicin provokes DNA damage and microglial activation at sub-lethal concentrations.
Rafael de la Hoz-Camacho, Ana Luisa Rivera-Lazarín, José Manuel Vázquez-Guillén, et al.
PubMed (2022) Vol. 21, pp. 197-212
Closed Access | Times Cited: 12
Clemastine Rescues Chemotherapy-Induced Cognitive Impairment by Improving White Matter Integrity
Yingxi Chen, Jie Sheng, Xiuying Tang, et al.
Neuroscience (2022) Vol. 484, pp. 66-79
Closed Access | Times Cited: 11
Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Jingjing Zhao, He Zuo, Ke Ding, et al.
PubMed (2020) Vol. 12, Iss. 6, pp. 3046-3056
Closed Access | Times Cited: 17
Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic Malignancy
Noha Sharafeldin, Joshua Richman, Alysia Bosworth, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 12, pp. 1312-1321
Open Access | Times Cited: 16
The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models – A systematic review
Olivia J. Haller, Ines Semendric, Rebecca P. George, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105120-105120
Open Access | Times Cited: 5
An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment
Kate Oppegaard, Samantha Mayo, Terri S. Armstrong, et al.
Nursing Research (2023)
Open Access | Times Cited: 5
Polydatin as a therapeutic alternative for central nervous system disorders: A systematic review of animal studies
Lúcia Emanueli Schimith, Michele Goulart dos Santos, Bruno Dutra Arbo, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2852-2877
Closed Access | Times Cited: 8

Scroll to top